Stem Cells: The Hidden Key to Unlocking a Life Free from Neurological Disorders
In the latest episode of The Stem Cell Healing Institute Podcast titled “Does Stem cell Therapy Effectively Treat Neurological Diseases?” Dr. Zahra Figueredo discusses the potential of stem cell therapy in treating neurological diseases. Neurological diseases, caused by damage or dysfunction to the brain, spinal cord, or nerves, can also be triggered by genetic factors, […]
Revolutionary Cell Therapy Shows Promise: Over 90% Seizure Reduction in Drug-Resistant Epilepsy Patients
Neurona Therapeutics, a clinical-stage biotherapeutics company, is developing regenerative cell therapies for the treatment of neurological disorders. They recently presented updated clinical data from their ongoing Phase I/II trial of NRTX-1001 in people with drug-resistant mesial temporal lobe epilepsy (MTLE) at the American Academy of Neurology 2023 Annual Meeting. The data showed a >90% reduction […]
Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients
A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]
Exploring Stem Cell Therapy for Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects millions of people around the world. While there currently is no cure, advances in stem cell research have offered new hope for those living with this chronic condition. In this blog post, we will delve into the potential benefits and risks associated with stem cell treatments […]
Neurona Therapeutics Presents Encouraging Clinical Data from First-Ever Regenerative Human Cell Therapy Trial in Adults with Drug-Resistant Focal Epilepsy and Shows Supporting Manufacturing, Delivery, and Preclinical Data
SAN FRANCISCO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the treatment of neurological disorders, announced that Cory R. Nicholas, Ph.D., Neurona’s president and chief executive officer, was invited to present an overview of Neurona’s regenerative cell therapy technology, proprietary manufacturing process, cell delivery system, and preclinical […]